Haute Autorité de Santé [En ligne]. Fibrillation auriculaire, Juillet, 2007. ,
Prevalence of Atrial Fibrillation and Association of Atrial Fibrillation with Prior and New Thromboembolic Stroke in Older Patients, Journal of the American Geriatrics Society, vol.323, issue.5, pp.521-524, 1996. ,
DOI : 10.1111/j.1532-5415.1996.tb01436.x
A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study, The American Journal of Medicine, vol.113, issue.5, pp.359-64, 2002. ,
DOI : 10.1016/S0002-9343(02)01236-6
Effect of Intensity of Oral Anticoagulation on Stroke Severity and Mortality in Atrial Fibrillation, New England Journal of Medicine, vol.349, issue.11, pp.1019-1045, 2003. ,
DOI : 10.1056/NEJMoa022913
Antithrombotic Therapy To Prevent Stroke in Patients with Atrial Fibrillation, Annals of Internal Medicine, vol.131, issue.7, pp.492-501, 1999. ,
DOI : 10.7326/0003-4819-131-7-199910050-00003
Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial, Lancet, vol.367, pp.1903-1915, 2006. ,
Effect of clopidogrel added to aspirin in patients with atrial fibrillation, N Engl J Med, vol.360, pp.2066-78, 2009. ,
Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial, The Lancet, vol.370, issue.9586, pp.493-503, 2007. ,
DOI : 10.1016/S0140-6736(07)61233-1
Dabigatran versus Warfarin in Patients with Atrial Fibrillation, New England Journal of Medicine, vol.361, issue.12, pp.1139-51, 2009. ,
DOI : 10.1056/NEJMoa0905561
Stroke prevention using the oral direct factor Xa inhibitor rivaroxaban compared with warfarine in patients with non-valvular atrial fibrillation. Late-breaking clinical trail II. Congrès de l, American Heart Association, pp.13-17, 2010. ,
2012 Focused Update of the ESC Guidelines for the Management of Atrial Fibrillation, Revista Espa??ola de Cardiolog??a (English Edition), vol.66, issue.1, pp.2719-2766, 2012. ,
DOI : 10.1016/j.rec.2012.11.003
Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach, Chest, vol.137, issue.2, pp.263-72, 2010. ,
DOI : 10.1378/chest.09-1584
A novel user-friendly score (HAS-BLED) to assess one-year risk of major bleeding in atrial fibrillation patients ,
Prise en charge des surdosages en antivitamines K, des situations à risque hémorragique et des accidents hémorragiques chez les patients traités par antivitamines K en ville et en milieu hospitalier, Avril, 2008. ,
Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT), The Lancet, vol.348, issue.9025, pp.423-431, 1996. ,
DOI : 10.1016/S0140-6736(96)01109-9
HRS Guideline for the Management of Patients With Atrial Fibrillation : A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation, 2014. ,
Quelle place pour les anticoagulants oraux non antivitamine K : apixaban (Eliquis®), dabigatran (Pradaxa®) et rivaroxaban (Xarelto®) ,
Atrial fibrillation as an independent risk factor for stroke: the Framingham Study, Stroke, vol.22, issue.8, pp.983-991, 1991. ,
DOI : 10.1161/01.STR.22.8.983
Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE), N Engl J Med, vol.365, pp.911-932, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-00930087
Atrial fibrillation management: a prospective survey in ESC Member Countries: The Euro Heart Survey on Atrial Fibrillation, European Heart Journal, vol.26, issue.22, pp.2422-2456, 2005. ,
DOI : 10.1093/eurheartj/ehi505
Increasing trends in hospitalization for atrial fibrillation in the United States, 1985 through 1999: implications for primary prevention, ACC Current Journal Review, vol.13, issue.1, pp.711-717, 2003. ,
DOI : 10.1016/j.accreview.2003.10.016
Incidence of and Risk Factors for Atrial Fibrillation in Older Adults, Circulation, vol.96, issue.7, pp.2455-61, 1997. ,
DOI : 10.1161/01.CIR.96.7.2455
Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study, JAMA: The Journal of the American Medical Association, vol.271, issue.11 ,
DOI : 10.1001/jama.271.11.840
Pulse Pressure and Risk of New-Onset Atrial Fibrillation, JAMA, vol.297, issue.7, pp.709-724, 2007. ,
DOI : 10.1001/jama.297.7.709
Temporal Relations of Atrial Fibrillation and Congestive Heart Failure and Their Joint Influence on Mortality: The Framingham Heart Study, Circulation, vol.107, issue.23, pp.2920-2925, 2003. ,
DOI : 10.1161/01.CIR.0000072767.89944.6E
Management of octogenarians hospitalized for heart failure in Euro Heart Failure Survey I, European Heart Journal, vol.28, issue.11, pp.1310-1318, 2007. ,
DOI : 10.1093/eurheartj/ehl443
Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates 11Reprints are not available., The American Journal of Cardiology, vol.82, issue.7, pp.2-9, 1998. ,
DOI : 10.1016/S0002-9149(98)00583-9
Warfarin for Stroke Prevention Still Underused in Atrial Fibrillation : Patterns of Omission, Stroke, vol.31, issue.6, pp.1217-1239, 2000. ,
DOI : 10.1161/01.STR.31.6.1217
Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation, European Heart Journal, vol.27, issue.24, pp.3018-3044, 2006. ,
DOI : 10.1093/eurheartj/ehl015
Translating the Results of Randomized Trials into Clinical Practice: The Challenge of Warfarin Candidacy Among Hospitalized Elderly Patients With Atrial Fibrillation, Stroke, vol.37, issue.4, pp.1075-80, 2006. ,
DOI : 10.1161/01.STR.0000209239.71702.ce
Prevalence, Functional Impact, and Mortality of Atrial Fibrillation in an Older Italian Population (from the Pro.V.A. Study), The American Journal of Cardiology, vol.104, issue.8, pp.1092-1099, 2009. ,
DOI : 10.1016/j.amjcard.2009.05.058
Atrial Fibrillation and Dementia in a Population-Based Study: The Rotterdam Study, Stroke, vol.28, issue.2, pp.316-337, 1997. ,
DOI : 10.1161/01.STR.28.2.316
Cognitive Impairment Associated With Atrial Fibrillation, Annals of Internal Medicine, vol.158, issue.5_Part_1, pp.338-384, 2013. ,
DOI : 10.7326/0003-4819-158-5-201303050-00007
Rationale and design of AVERROES: Apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment, American Heart Journal, vol.159, issue.3, pp.348-53, 2010. ,
DOI : 10.1016/j.ahj.2009.08.026
Comparative Validation of a Novel Risk Score for Predicting Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation, Journal of the American College of Cardiology, vol.57, issue.2, pp.173-80, 2011. ,
DOI : 10.1016/j.jacc.2010.09.024
Prise en charge des complications hémorragiques graves et de la chirurgie en urgence chez les patients recevant un anticoagulant oral anti-IIa ou anti-Xa direct ,